Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion type Assertion NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_head.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion evidence source_evidence_literature NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion SIO_000772 7545221 NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion wasDerivedFrom befree-20140225 NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.
- NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_assertion wasGeneratedBy ECO_0000203 NP422551.RAfigAgRuht6CHmAEKAXr9L7CEWSmyTw3o5GG2lLIa5oU130_provenance.